Tower Research Capital LLC (Trc) Rockwell Medical, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,479 shares of RMTI stock, worth $2,702. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,479
Previous 7,734
67.95%
Holding current value
$2,702
Previous $15,000
86.67%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding RMTI
# of Institutions
53Shares Held
7.13MCall Options Held
92.8KPut Options Held
14.9K-
Armistice Capital, LLC New York, NY2.37MShares$2.58 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.21MShares$1.31 Million0.0% of portfolio
-
Globeflex Capital L P San Diego, CA743KShares$810,1490.08% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny453KShares$493,7710.0% of portfolio
-
Marshall Wace, LLP London, X0334KShares$363,6180.0% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $11.6M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...